Search results for: Adrian Towse
Filter search results
New OHE Research Paper: Uncertainty and Risk in HTA Decision Making
7 December 2016
…key modelling assumptions or data sources. The potential for efficiently collecting more information should be explored. Download the full paper here. For more information please contact Adrian Towse at OHE….
New Publication: Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value
7 March 2017
…Summit. Just published is a new report entitled: Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value. The report was developed by OHE’s Grace Marsden and Adrian…
HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making
2 May 2017
…worked with HTAi, Chris Henshall, and the global pharmaceutical industry to establish the AHPF in 2013. OHE’s Adrian Towse and Grace Hampson provided the scientific secretariat for the first four…
Incentives for New Drugs and Vaccines to Tackle Anti-Microbial Resistance
16 May 2017
…a set of pull incentives to drive new antibiotic and vaccine R&D in Europe and globally. Access the full report here. For more information please contact Adrian Towse at OHE….
OHE at iHEA Boston 2017: Meet the Team
5 July 2017
…York) and Prof. Adrian Towse (OHE). In addition, Paula Lorgelly, with Carl Ashe (University of Illinois), has organised a ‘Special Organised Session’ (akin to a mini plenary) on Value Frameworks:…
Assessing Value, Budget Impact, and Affordability in Asia
10 July 2017
…the International Journal of Technology Assessment in Health Care. This paper, written by OHE’s Grace Hampson and Adrian Towse, along with Chair of the HTAi Asia Policy Forum Chris Henshall,…
An Insurance Framework for Funding New Antibiotics
22 September 2017
…on a Policy of Risk Mitigation” has been published online in Health Policy OHE Director Adrian Towse and OHE Visiting Fellow Jorge Mestre-Ferrandiz are co-authors along with Chris Hoyle, Jonathan…
What do Pharmaceuticals Really Cost in the Long Run?
6 October 2017
Drug prices in the US might overstate pharmaceuticals’ long-run cost up to 75%. True long-term costs then must be considered by market access and policy decisions. OHE’s Adrian Towse and…
Value Frameworks: Value in Health Special Issue
29 March 2018
…existing frameworks, and; outline a set of best practice recommendations. OHE’s Adrian Towse was a member of the Special Task Force and is a co-author of three of the papers. OHE…